Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nanexa | NANEXA | Mar 18, 2024 | 0.82 | -4.19 |
NanoCap Group B | NANOCB | Mar 18, 2024 | 5.05 | -5.61 |
Nanoform Finland | NANOFS | Mar 18, 2024 | 31.00 | -3.13 |
Nanologica | NICA | Mar 18, 2024 | 6.50 | -2.40 |
NASDAQ OMX Small Cap Sweden GI | NOMXSCSEGI | Mar 18, 2024 | 3 995.65 | -0.39 |
NASDAQ OMX Small Cap Sweden PI | NOMXSCSE | Mar 18, 2024 | 2 517.24 | -0.39 |
Nattaro Labs | NATTA | Mar 18, 2024 | 0.70 | +1.45 |
Navigo Invest AB | NAVIGOSTAM | Mar 18, 2024 | 4.08 | -0.24 |
Navigo Invest Pref | NAVIGOPREF | Mar 18, 2024 | 106.50 | +0.47 |
NAXS | NAXS | Mar 18, 2024 | 64.20 | -2.43 |
NCAB Group | NCAB | Mar 18, 2024 | 60.75 | -6.03 |
NCC A | NCCA | Mar 18, 2024 | 143.50 | -1.37 |
NCC B | NCCB | Mar 18, 2024 | 142.60 | -1.25 |
Nederman Holding | NMAN | Mar 18, 2024 | 173.00 | +0.87 |
NEL | NELO | Mar 18, 2024 | 4.72 | -2.80 |
Nelly Group | NELLY | Mar 18, 2024 | 16.80 | -2.33 |
Neobo Fastigheter | NEOBO | Mar 18, 2024 | 16.28 | +0.37 |
NeoDynamics | NEOD | Mar 18, 2024 | 0.99 | -2.86 |
Neola Medical | NEOLA | Mar 18, 2024 | 1.64 | -2.97 |
Nepa | NEPA | Mar 18, 2024 | 30.10 | +7.50 |
Net Insight B | NETIB | Mar 18, 2024 | 6.13 | 0.00 |
Netel | NETEL | Mar 18, 2024 | 11.45 | +0.88 |
NetJobs Group | NJOB | Mar 18, 2024 | 0.29 | 0.00 |
New Nordic Healthbrands | NNH | Mar 18, 2024 | 21.00 | 0.00 |
New Wave B | NEWAB | Mar 18, 2024 | 124.14 | -0.43 |
Newbury Pharmaceuticals | NEWBRY | Mar 18, 2024 | 3.83 | +3.23 |
News55 | N55 | Mar 18, 2024 | 3.04 | 0.00 |
Nexam Chemical Holding | NEXAM | Mar 18, 2024 | 3.25 | -1.22 |
Nexar Group | NXAR | Mar 18, 2024 | 0.23 | +13.30 |
NextCell Pharma AB | NXTCL | Mar 18, 2024 | 3.39 | +7.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.